S. Morry Blumenfeld is the President and CEO of Quescon Consultants, Ltd, a medical device consulting company and is a Founding Partner of Meditech Advisors Management, a General Partner in Ziegler Meditech Equity Partners.
Dr. Blumenfeld retired from GE in 2002, having been with GE for over 34 years, with the last 27 years of his career at GE with GE Healthcare, ending as Managing Director of GE Medical Systems in Israel. Dr. Blumenfeld has considerable experience in developing and commercializing large-scale diagnostic imaging systems as well as new image guided equipment designed to provide non-invasive and minimally invasive procedures. Among other accomplishments, Dr. Blumenfeld was one of the managers responsible for the initial development of GE’s computed tomography (“CT”) and magnetic resonance imaging (“MRI”) product lines. He was also responsible during this period for many of the new MR developments, including advanced cardiac MR, very high field MR systems, the first Intra-Operative MR System as well as the initiation of MR guided focused ultrasound.
Dr. Blumenfeld is a prominent authority on the development of healthcare technology including imaging devices and devices for minimally invasive procedures, and has advised or consulted with many medical research centers, universities, health technology companies and research hospitals across the USA, Europe and Asia through his work with CT, MRI and Focused Ultrasound, as well as other healthcare technologies,. He serves or has served as a Director of a number of private and public companies and on a number of academic advisory boards, including the Hebrew University's Yissum, and the SAB of Tel Aviv University's Ramot's Momentum Fund. He serves as Chairman of the Medical Advisory Board of OurCrowd, an equity-based crowd funding platform.
Morry holds five patents, and in 1977, GE’s Centennial Year, received the GE Centennial Award for his work in CT.